On July 30, 2021 Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) reported that it has been continuously included as a constituent stock in all indices of the Japanese equities for environmental, social and governance (ESG) investment selected by the Government Pension Investment Fund (GPIF) of Japan (Press release, Chugai, JUL 30, 2021, View Source [SID1234585462]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
FTSE Blossom Japan Index (commenced investment from July 2017):
An index designed to reflect the performance of Japanese companies demonstrating excellent environmental, social, and governance practices.
MSCI Japan ESG Select Leaders Index (commenced investment from July 2017):
An index created from the stocks of companies with a relatively high ESG rating in each industry from among the top 700 Japanese companies by market capitalization.
MSCI Japan Empowering Women Index (WIN) (commenced investment from July 2017):
An index created from a selection of companies with excellent gender diversity practices in each industry from among the top 700 Japanese companies by market capitalization.
S&P/JPX Carbon Efficient Index (commenced investment from September 2018):
An index designed to measure the performance of companies in the Tokyo Stock Price Index (TOPIX) based on disclosures of environmental information and levels of carbon efficiency.
*Chugai is included in all four ESG indices since the initiation of ESG investment.
The sustainability of Chugai has been highly regarded in terms of ESG practices, as Chugai has been selected as a constituent in the FTSE4Good Index Series for the 19th consecutive year and in the MSCI ESG Leaders Indexes for the 12th consecutive year, both of which are major ESG indices. In addition, we have continued to receive an "AA," rating, the second-highest of the seven levels in the MSCI ESG rating that evaluates ESG risk tolerance, indicating that our risk tolerance to various ESG risks that may occur in the future is relatively high.
Chugai’s basic management policy is "creating shared value between our company and society" and "realize advanced and sustainable medical care centered on patients." This philosophy is also in line with the "Sustainable Development Goals (SDGs)" set by the United Nations. Chugai will continue to strive for appropriate disclosure of information on the SDGs and ESG initiatives, create value for patients and society by leveraging innovation that only Chugai can provide, and contribute to solving social issues and building a sustainable society through our business activities.